专题：Cancer Diagnosis and Treatment

This cluster of papers focuses on the diagnosis, treatment, and molecular characterization of Cancer of Unknown Primary (CUP) site. It includes research on metastatic patterns, molecular profiling to identify tissue of origin, immunohistochemical markers, diagnostic algorithms, and clinical management strategies.
最新文献
Causes of death among people living with metastatic cancer

article Full Text OpenAlex

Reirradiation of bone metastasis: A narrative review of the literature

review Full Text OpenAlex

Racial Disparities in Patients with Metastatic Tumors of the Spine: A Systematic Review

review Full Text OpenAlex

Accessing breast cancer care in a protracted conflict: Qualitative exploration of the perspectives of women with breast cancer in northwest Syria

article Full Text OpenAlex

Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases

article Full Text OpenAlex

Collateralization of the upper extremity lymphatic system after axillary lymph node dissection

article Full Text OpenAlex

Advances of 3D printing in oral oncology: personalized technologies for patients – a narrative review

review Full Text OpenAlex

PCGF2 Acts as an Oncogenic Driver in Colon Cancer through the Upregulation of CENPE

article Full Text OpenAlex

Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers

article Full Text OpenAlex

Recurrent respiratory papillomatosis: comparing in-office and operating room treatments

article Full Text OpenAlex

近5年高被引文献
American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update

review Full Text OpenAlex 861 FWCI127.96067313

Head and neck cancer

review Full Text OpenAlex 700 FWCI123.45602456

AI-based pathology predicts origins for cancers of unknown primary

article Full Text OpenAlex 541 FWCI42.66641789

Metastasis to thyroid gland

reference-entry Full Text OpenAlex 298 FWCI0

A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.

article Full Text OpenAlex 228 FWCI68.33461959

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

review Full Text OpenAlex 206 FWCI23.87788759

Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study

article Full Text OpenAlex 198 FWCI28.65346511

Novel approaches to target the microenvironment of bone metastasis

review Full Text OpenAlex 180 FWCI16.14405001

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

article Full Text OpenAlex 169 FWCI55.33289993

Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

review Full Text OpenAlex 167 FWCI77.18982626